Woodley BioReg is pleased to announce that we will be attending Dubai Derma in April for the first time. As regulatory and quality assurance experts in the pharmaceutical, biotechnology, and medical device industries, we recognise the vital role that regulation plays in ensuring the safety, efficacy, and compliance of skincare products.
The Growing Importance of Skincare Regulation
The skincare and dermatology sector is evolving rapidly, with new technologies, biopharmaceutical innovations, and aesthetic treatments entering the market at an unprecedented rate. However, as innovation accelerates, so does the need for robust regulatory frameworks to ensure patient safety and product effectiveness.
At Woodley BioReg, we have extensive experience supporting the aesthetics and pharmaceutical sectors in the development, certification, and registration of a wide range of dermatological products, including botulinum toxins, skin boosters, and fillers. Given our deep expertise in this area, attending Dubai Derma presents an excellent opportunity to share our knowledge and explore new ways to accelerate and support product development for businesses looking to bring innovative skincare solutions to market.
In the UK, regulatory oversight for skincare products falls under the Medicines and Healthcare products Regulatory Agency (MHRA), ensuring that cosmetic and medical-grade skincare treatments meet stringent safety and efficacy standards. Meanwhile, in the Middle East and North Africa (MENA) region, regulatory pathways are evolving, requiring manufacturers and distributors to stay ahead of changing compliance requirements.
At Dubai Derma 2025, Woodley BioReg will bring its global regulatory expertise to discussions on how skincare and dermatology products can meet international compliance standards, ensuring safe market access across multiple regions.
Why Dubai Derma?
Dubai Derma is the largest scientific skincare gathering in the Middle East, North Africa and the Indian Subcontinent region. Now in its 24th edition, the event brings together skincare specialists, industry leaders, and key decision-makers from around the world.
With the rise of personalised skincare, regenerative medicine, and advanced aesthetic treatments, regulatory strategies must adapt to address novel ingredients, biotechnological developments, and evolving consumer expectations. Dubai Derma presents an exciting opportunity to engage with industry leaders and regulatory bodies, fostering collaboration on best practices in compliance, clinical evaluation, and product safety.
Looking Ahead
At Woodley BioReg, we are committed to helping businesses navigate complex regulatory landscapes, ensuring that their skincare and dermatology innovations meet both local and global compliance standards.
By attending Dubai Derma, we aim to not only share our regulatory expertise but also engage with businesses looking to streamline their pathway to market. Whether you’re a manufacturer, distributor, or innovator in the skincare space, we’re here to help you ensure compliance and achieve commercial success.
We look forward to the insights and opportunities Dubai Derma will bring and welcome discussions with industry professionals, manufacturers, and stakeholders who are navigating the ever-changing regulatory environment.
If you’re attending Dubai Derma, we’d love to connect. Get in touch with us to arrange a meeting and discuss how Woodley BioReg can support your regulatory and quality assurance needs.
Back to News + Insights